Literature DB >> 15260002

The use of tumor necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis in Lebanon.

Imad Uthman, Kamel Mroueh, Thuraya Arayssi, Fuad Nasr, Abdul-Fattah Masri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15260002     DOI： 10.1016/j.semarthrit.2003.12.005

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN： 0049-0172            Impact factor:   5.532


× No keyword cloud information.
  3 in total

1.  Infliximab as monotherapy in giant cell arteritis.

Authors:  Imad Uthman; Nadim Kanj; Samir Atweh
Journal:  Clin Rheumatol       Date:  2005-05-18       Impact factor: 2.980

2.  The use of biological therapy in refractory rheumatic diseases other than rheumatoid arthritis: experience at a tertiary care center in Lebanon.

Authors:  Khaled M Musallam; Thurayya Arayssi; Ali T Taher; Nadim Kanj; Imad Uthman
Journal:  Rheumatol Int       Date:  2008-12-04       Impact factor: 2.631

3.  The Use of Infliximab (Remicade®) for the Treatment of Rheumatic Diseases at a Tertiary Center in Lebanon: A 17-Year Retrospective Chart Review.

Authors:  Vicky Nahra; Georges El Hasbani; Monique Chaaya; Imad Uthman
Journal:  Mediterr J Rheumatol       Date:  2020-12-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.